Intensity Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INTS and other ETFs, options, and stocks.About INTS
Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine.
CEOLewis H. Bender
CEOLewis H. Bender
Employees16
Employees16
HeadquartersShelton, Connecticut
HeadquartersShelton, Connecticut
Founded2012
Founded2012
Employees16
Employees16
INTS Key Statistics
Market cap7.06M
Market cap7.06M
Price-Earnings ratio-0.23
Price-Earnings ratio-0.23
Dividend yield—
Dividend yield—
Average volume7.31M
Average volume7.31M
High today$0.28
High today$0.28
Low today$0.1853
Low today$0.1853
Open price$0.271
Open price$0.271
Volume9.46M
Volume9.46M
52 Week high$4.93
52 Week high$4.93
52 Week low$0.1853
52 Week low$0.1853
People also own
Based on the portfolios of people who own INTS. This list is generated using Robinhood data, and it’s not a recommendation.